300804 廣康生化
按盤價 
38.040 -0.040 (-0.105%)
38.040 -0.040 (-0.105%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.042 | 3.027 | 2.659 | 3.177 | 17.221 |
| 總資產報酬率 ROA (%) | -0.026 | 1.937 | 1.817 | 2.174 | 11.335 |
| 投入資產回報率 ROIC (%) | -0.030 | 2.246 | 2.029 | 2.361 | 12.839 | 邊際利潤分析 |
| 銷售毛利率 (%) | 19.182 | 24.144 | 20.756 | 24.030 | 29.281 |
| 營業利潤率 (%) | -0.653 | 6.256 | 4.075 | 6.286 | 16.105 |
| 息稅前利潤/營業總收入 (%) | 2.035 | 8.073 | 6.204 | 7.752 | 15.753 |
| 淨利潤/營業總收入 (%) | -0.239 | 5.355 | 4.733 | 6.075 | 14.574 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 129.240 | 98.030 | 64.687 | 95.130 | 103.847 |
| 價值變動淨收益/利潤總額(%) | -78.074 | 15.633 | 28.003 | 13.271 | 0.000 |
| 營業外收支淨額/利潤總額(%) | 38.755 | -10.890 | 14.690 | -1.657 | -2.663 | 償債能力分析 |
| 流動比率 (X) | 1.877 | 1.710 | 2.039 | 2.040 | 1.282 |
| 速動比率 (X) | 1.391 | 1.363 | 1.753 | 1.721 | 0.890 |
| 資產負債率 (%) | 36.427 | 38.298 | 33.329 | 29.789 | 35.101 |
| 帶息債務/全部投入資本 (%) | 27.035 | 27.470 | 20.753 | 24.149 | 24.911 |
| 股東權益/帶息債務 (%) | 264.723 | 259.166 | 373.771 | 310.606 | 292.624 |
| 股東權益/負債合計 (%) | 174.402 | 161.016 | 199.875 | 235.690 | 184.890 |
| 利息保障倍數 (X) | 0.656 | 3.321 | 4.348 | 4.943 | 239.800 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 95.413 | 84.932 | 81.727 | 100.651 | 61.728 |
| 存貨周轉天數 (天) | 162.179 | 116.395 | 95.970 | 118.403 | 81.800 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 12/06/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
